Five-year survival rate and factors affecting the survival of hemodialysis patients

How to Cite:Danial HabibiSarkav UsefiAzam MoslemiFive-year survival rate and factors affecting the survival of hemodialysis patients.koomesh.21(2):e153067.

Abstract

Introduction: Survival rate is important in chronic kidney disease patients due to their dependence on hemodialysis. Therefore, the aim of this study was to evaluate the survival rate of five- years and factors affecting the survival of hemodialysis patients. Materials and Methods: This historical cohort study was performed in 60 hemodialysis patients admitted to Kamyaran Sina Hospital (Iran). Statistical analysis was done using the Kaplan-Meier curve and compared by the Log-Rank test. Correspondingly, to determine the most important factors affecting the prognosis of survival of patients, we used Cox regression model. Results: The mean and median survival was 31.4 months and 34 months respectively. The survival rate of 1 year, 2 years, 3 years, 4 years and 5 years for patients were 84%, 60%, 49%, 25% and 10%, respectively. The mean albumin was significant based on the Cox regression. Conclusion: The results of Cox regression indicated that the mean of albumin was the most important factor and also had a protective effect on hemodialysis patients. Remarkably, the survival rates of these patients will be increased if the mean of albumin has an increase.

Keywords

Survival Analysis

Renal Dialysis

Chronic Kidney Failure

تحلیل بقا

دیالیز کلیوی

نارسایی مزمن کلیه

References

1.
Teixeira FI, Lopes ML, Silva GA, Santos RF. Survival of hemodialysis patients at a university hospital. J Bras Nefrol 2015; 37: 64-71.
2.
Sharma S, Sarnak MJ. Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality. Nature Rev Nephrol 2017; 13: 447-448.
3.
Mousavi SSB, Soleimani A, Mousavi MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi J Kidney Dis Transpl 2014; 25: 697-702.
4.
Control CfD, Prevention. Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007; 56: 161-165.
5.
Asgari MR, Motlagh NH, Soleimani M, Ghorbani R. Effect of lidocaine spray on the pain intensity during insertion of vascular needles in hemodialysis patients. Koomesh 2013; 14. (Persian).
6.
Sohrabi Z, Salehi M, Ekramzade M, Sagheb MM, Ayatollahi M, Hassanzade J. Effect of selenium supplement on quality of life in hemodialysis patients. Koomesh 2015; 16. (Persian).
7.
Cheung CM, Hegarty J, Kalra PA. Dilemmas in the management of renal artery stenosis. Br Med Bull 2005; 73: 35-55.
8.
Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol 2006; 1: 710-717.
9.
Singapuri MS, Lea JP. Management of hypertension in the end-stage renal disease patient. JCOM 2010; 17.
10.
Jablonski A. The multidimensional characteristics of symptoms reported by patients on hemodialysis. Nephrol Nurs J 2007; 34: 29-37.
11.
Rambod H. Chronic renal failure. Sci Dial Patient Nurs Phys 2008; 3: 1-2.
12.
Abede M, Aghaee N, Gholame F. Evaluation of hemodialysis adequacy on patients undergoing hemodialysis in Razi Hospital in Rasht. J Med Facul Mazanderan Univ Med Sci 2010; 23: 20-27. (Persian).
13.
Ghods AJ, Savaj S. Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol 2006; 1: 1136-1145.
14.
Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, et al. Excerpts from the US renal data system 2009 annual data report. Am J Kidney Dis 2010; 55: S1-420.
15.
Raiesifar A, Torabpour M, Mohsenizad P. Causes of chronic renal failure in hemodialysis patients of Abadan. J Crit Care Nurs 2010; 2: 11-12. (Persian).
16.
Habibi D, Rafiei M, Chehrei A, Shayan Z, Tafaqodi S. Comparison of survival models for analyzing prognostic factors in gastric cancer patients. Asian Pac J Cancer Prev 2018; 19: 749-753.
17.
Montaseri M, Charati JY, Espahbodi F, Mousavi SJ. Five-year survival rate in hemodialysis patients attending Sari Imam Khomeini hospital. J Mazandaran Univ Med Sci 2013; 23: 78-85. (Persian).
18.
Shabankhani B, Kazemnejad A, Zaeri F, Espahbodi F, Ahmadi MH, Mirkazemi R. Survival factors in patients with end-stage renal disease in Mazandaran province, Iran. Iran J Kidney Dis 2016; 10: 79-84.
19.
Yeates A, Hawley C, Mundy J, Pinto N, Haluska B, Shah P. Treatment outcomes for ischemic heart disease in dialysis-dependent patients. Asian Cardiovasc Thorac Ann 2012; 20: 281-291.
20.
Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 2002; 13: 1889-1893.
21.
Argyropoulos C, Chang CC, Plantinga L, Fink N, Powe N, Unruh M. Considerations in the statistical analysis of hemodialysis patient survival. J Am Soc Nephrol 2009; 20: 2034-2043.

comments